八通生物 (872017.OC)

+ 收藏

现金流量表(八通生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 6,731,830.1017,159,923.026,659,484.7551,615,459.1928,600,957.00
 收到的税费返还(元) 35,600.00-53,800.00-85,647.07
 收到其他与经营活动有关的现金(元) 1,443,440.511,017,640.43220,213.901,930,448.83113,287.00
 经营活动现金流入小计(元) 8,210,870.6118,177,563.456,933,498.6553,545,908.0228,799,891.07
 购买商品、接受劳务支付的现金(元) 1,294,370.243,512,731.252,337,898.7734,752,328.6314,644,097.75
 支付给职工以及为职工支付的现金(元) 5,775,252.3113,244,636.657,163,824.6314,430,344.997,718,194.50
 支付的各项税费(元) 325,976.213,331,023.642,860,620.012,282,959.671,082,878.05
 支付其他与经营活动有关的现金(元) 3,210,572.296,969,556.493,518,687.767,553,554.265,010,222.83
 经营活动现金流出小计(元) 10,606,171.0527,057,948.0315,881,031.1759,019,187.5528,455,393.13
 经营活动产生的现金流量净额(元) -2,395,300.44-8,880,384.58-8,947,532.52-5,473,279.53344,497.94
二、投资活动产生的现金流量
 收回投资收到的现金(元) 2,500,000.001,500,000.001,000,000.00112,200,000.0099,000,000.00
 取得投资收益收到的现金(元) 7,003.2467,241.5036,161.42607,452.76344,150.15
 投资活动现金流入小计(元) 2,507,003.241,567,241.501,036,161.42112,807,452.7699,344,150.15
 购建固定资产、无形资产和其他长期资产支付的现金(元) 1,198,352.25470,810.00-1,496,384.601,365,464.60
 投资支付的现金(元) ---80,000,000.0076,000,000.00
 投资活动现金流出小计(元) 1,198,352.25470,810.00-81,496,384.6077,365,464.60
 投资活动产生的现金流量净额(元) 1,308,650.991,096,431.501,036,161.4231,311,068.1621,978,685.55
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 5,000,000.004,000,000.004,000,000.00--
 筹资活动现金流入小计(元) 5,000,000.004,000,000.004,000,000.00--
 偿还债务支付的现金(元) 4,000,000.00--5,000,000.00-
 分配股利、利润或偿付利息支付的现金(元) -114,566.66-20,705,027.77-
 筹资活动现金流出小计(元) 4,000,000.00114,566.66-25,705,027.77-
 筹资活动产生的现金流量净额(元) 1,000,000.003,885,433.344,000,000.00-25,705,027.77-
五、现金及现金等价物净增加额(元) -86,649.45-3,898,519.74-3,911,371.10132,760.8622,323,183.49
 加:期初现金及现金等价物余额(元) 2,206,402.806,104,922.546,104,922.545,972,161.685,972,161.68
 期末现金及现金等价物余额(元) 2,119,753.352,206,402.802,193,551.446,104,922.5428,295,345.17
补充资料:
 净利润(元) -3,397,510.82-24,813,225.66-1,700,722.933,825,376.783,105,974.89
 固定资产和投资性房地产折旧(元) 333,783.08714,899.17363,012.60681,628.61300,877.95
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 333,783.08714,899.17363,012.60681,628.61300,877.95
 无形资产摊销(元) 5,863.1441,418.0922,751.1036,362.1616,657.74
 长期待摊费用摊销(元) 104,195.72100,255.5041,760.003,178,612.311,793,700.45
 财务费用(元) 153,320.40138,861.2939,983.2245,365.4932,689.60
 投资损失(元) -7,003.24-67,241.50-36,161.42-607,452.76-344,150.15
 递延所得税(元) -743.79-20,943.15-78,895.50-9,556.13-14,519.14
  其中:递延所得税资产减少(元) -743.79-500,499.23-78,895.50-9,556.13-14,519.14
 递延所得税负债增加(元) -479,556.08---
 存货的减少(元) 635,611.006,329,940.174,285,670.87-1,998,425.74-1,342,375.38
 经营性应收项目的减少(元) -74,432.69-8,006,498.31-13,807,184.761,616,141.72-447,641.50
 经营性应付项目的增加(元) -609,756.65-5,362,615.011,375,665.20-13,716,530.43-2,932,256.46
 其他(元) -----24,800.00
 不涉及现金收支的投资和筹资活动金额其他项目(元) 5,328,574.095,345,429.14---
 现金的期末余额(元) 2,149,753.352,206,402.802,193,551.446,104,922.5428,295,345.17
 减:现金的期初余额(元) 2,236,402.806,104,922.546,104,922.545,972,161.685,972,161.68
 现金及现金等价物的净增加额(元) -86,649.45-3,898,519.74-3,911,371.10132,760.8622,323,183.49
公告日期 2024-08-282024-04-262023-08-282023-04-282022-08-29
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院